Porcine Vaccine Market Trends and Industry Forecast 2016 – 2024 Porcine Vaccine Market - North America Industry An | Page 2

segment. Different types of end-user utilize porcine vaccines to treat swine diseases either. Under the
end-user segment, hog/pig production farms plays a major role followed by veterinary hospitals. The
market size and forecast in terms of US$ Mn for each segment have been provided for the period from
2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market
segment for the forecast period from 2016 to 2024, considering 2015 as the base year.
North America Porcine Vaccine Market: Geographical and Competitive Dynamics
Geographically, the North America porcine vaccine market has been categorized into key countries:
North America (the U.S. and Canada). The market size and forecast for each of these regions and the
mentioned countries have been provided for the period from 2014 to 2024, along with their respective
CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.
The report also profiles major players in the North America porcine vaccine market based on various
attributes such as company overview, financial overview, product portfolio, business strategies, SWOT
analysis, and recent developments. Major players profiled in this report include Bayer AG., Bimeda
Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company),
Merck & Co., Inc., Merial (Sanofi), Vetoquinol, Zoetis Inc. and others.
Get accurate market forecast and analysis on the Porcine Vaccine market. Request a sample to stay
abreast on the key trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16976
The North America porcine vaccine market has been segmented as follows:
North America Porcine Vaccine Market, by Disease Indication
 Diarrhoea
 Swine Influenza
 Arthritis
 Bordatella Rhinitis
 Porcine Reproductive and Respiratory Virus (PRRSV)
 Porcine Circovirus Associated Disease (PCVAD)
 Others
North America Porcine Vaccine Market, by Technology
 Inactivated Vaccines
 Live Attenuated Vaccines
 Toxoid Vaccines
 Recombinant Vaccines
 Conjugate Vaccines
 DNA Vaccines
North America Porcine Vaccine Market, by End-user
 Veterinary Hospitals
 Hog/Pig Production Farm
North America Porcine Vaccine Market, by Country
 North America
o U.S.
o Canada